15 research outputs found
Scenario analyses, societal perspective.
*<p>Mixed public and private incremental vaccine cost was calculated by weighing the public and private vaccine cost by the proportion of those who receive the vaccine at public cost.</p
Probabilistic sensitivity analysis, societal perspective.
<p>Probabilistic sensitivity analysis, societal perspective.</p
Pertussis cases avoided by vaccinating 10% of US population aged 65 years.
<p>Pertussis cases avoided by vaccinating 10% of US population aged 65 years.</p
Incremental costs from vaccinating 10% of US population aged 65 years.
<p>Incremental costs from vaccinating 10% of US population aged 65 years.</p
Model inputs and sources for adults aged 65 years.
*<p>Vaccine cost was estimated as the incremental cost of Tdap versus Td and included drug acquisition cost and cost of vaccine adverse events (Lee 2007).</p>**<p>Cost is lost productivity per case and is applied to moderate and severe cases only.</p><p>PSA = probabilistic sensitivity analysis.</p
Incremental cost per case averted and per QALY gained (89% efficacy), societal perspective.
<p>Incremental cost per case averted and per QALY gained (89% efficacy), societal perspective.</p
Incremental Costs of Intervention Strategy.
<p>Incremental Costs of Intervention Strategy.</p
Cases Avoided with Intervention Strategy, by Age Group, Case Severity, and Treatment.
<p>Cases Avoided with Intervention Strategy, by Age Group, Case Severity, and Treatment.</p